Peter W Hansen
Novo Nordisk (Denmark)(DK)
Publications by Year
Research Areas
Copyright and Intellectual Property, Antiplatelet Therapy and Cardiovascular Diseases, Intellectual Property Law, Atrial Fibrillation Management and Outcomes, Aortic aneurysm repair treatments
Most-Cited Works
- → Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarction(2019)96 cited
- → Long‐term use of proton pump inhibitors, dose–response relationship and associated risk of ischemic stroke and myocardial infarction(2017)84 cited
- → Influence of age on perioperative major adverse cardiovascular events and mortality risks in elective non-cardiac surgery(2016)35 cited
- → Mortality associated with cardiovascular drugs in patients with chronic obstructive pulmonary disease and right-sided heart failure – A danish nationwide registry-based study(2019)28 cited
- → Identifying Drug–Drug Interactions by Data Mining(2016)25 cited
- → Noncardiac Surgery in Patients With Aortic Stenosis: A Contemporary Study on Outcomes in a Matched Sample From the Danish Health Care System(2014)22 cited
- → Trends in warfarin use and its associations with thromboembolic and bleeding rates in a population with atrial fibrillation between 1996 and 2011(2018)16 cited
- → O-007 Natural History of Acute Ischaemic Stroke from Large Vessel Occlusion Demonstrates Efficacy of Mechanical Thrombectomy: Preliminary Results of the Penumbra FIRST Study(2013)4 cited
- Abstract 18462: Proton Pump Inhibitor Use Increases the Associated Risk of First-Time Ischemic Stroke. A Nationwide Cohort Study(2016)
- → The benefits of weight loss, even if regained, in reducing cardiovascular disease: welcoming evidence!(2014)1 cited